Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Bupropion Hydrochloride

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Wellbutrin;Zyban;Voxra;Budeprion;Aplenzin;Bupropion

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axsome Presents AUVELITY Depression Data at ASCP 2026
    Axsome Presents AUVELITY Depression Data at ASCP 2026

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/26/3300945/33090/en/axsome-therapeutics-presents-new-auvelity-data-in-major-depressive-disorder-at-the-american-society-of-clinical-psychopharmacology-ascp-2026-annual-meeting.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    Yichang Humanwell’s Generics Bupropion Receives Approval in US
    Yichang Humanwell’s Generics Bupropion Receives Approval in US

    04 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220529

    FDA
    04 May 2026
    Share Share
    Currax Expands Obesity Treatment Access via PeekDirect™
    Currax Expands Obesity Treatment Access via PeekDirect™

    01 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-expands-patient-access-to-fda-approved-obesity-treatment-with-peekdirect-302731360.html

    PR NEWSWIRE
    01 Apr 2026
    Share Share
    Enforcement Report - Week of October 29, 2025
    Enforcement Report - Week of October 29, 2025

    29 Oct 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-29-2025-82388.pdf

    FDA
    29 Oct 2025
    Share Share
    Annora`s Generics Bupropion Hydrochloride Receives Approval in US
    Annora`s Generics Bupropion Hydrochloride Receives Approval in US

    01 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217898

    FDA
    01 Oct 2025
    Share Share
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety

    11 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-peer-reviewed-study-in-obesity-pillars-further-substantiates-cardiovascular-safety-profile-of-contravemysimba-302397897.html

    PR NEWSWIRE
    11 Mar 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.